AUROPHARMA

Mon, 5 Oct, 2026

• News

  Moneycontrol news article on stock price movement

  moneycontrol.com ↗

Fri, 2 Oct, 2026

• FilingAurobindo Pharma Limited announces acquisition of an undisclosed target companyNSE ↗
• FilingAurobindo Pharma completes acquisitionNSE ↗
• Filing

  Company acquires a step-down subsidiary in USA

  BSE ↗
• Filing

  Acquisition completion disclosed under Regulation 30

  BSE ↗

Thu, 1 Oct, 2026

• News

  Aurobindo Pharma launches Adquey in the US market

  cnbctv18.com ↗
• FilingAurobindo Pharma Limited has informed the exchange about an acquisitionNSE ↗
• Filing

  Step-down subsidiary A1 Biochem Labs allotted shares under acquisition

  BSE ↗

Wed, 30 Sept, 2026

• News

  Acrotech Biopharma launches ADQUEY in US dermatology market

  cnbctv18.com ↗
• Filing

  Company launches ADQUEY in the U.S. market and establishes dedicated dermatology business

  BSE ↗

Thu, 17 Sept, 2026

• News

  USFDA issued one observation for Aurobindo Pharma's Telangana facility

  moneycontrol.com ↗

Wed, 16 Sept, 2026

• News

  US FDA inspection of Telangana API facility concludes with 1 procedural observation

  cnbctv18.com ↗

Tue, 15 Sept, 2026

• News

  US FDA inspection at Telangana API facility concludes with one procedural observation

  cnbctv18.com ↗

Wed, 16 Sept, 2026

• News

  USFDA issued one observation for Aurobindo Pharma's Telangana facility

  moneycontrol.com ↗

Tue, 15 Sept, 2026

• News

  Aurobindo Pharma received US FDA approval for metered Beclomethasone Dipropionate aerosol

  business-standard.com ↗
• News

  NDTV Profit news article reporting Aurobindo Pharma's first USFDA approval for a metered-dose inhaler

  ndtvprofit.com ↗
• Filing

  Aurobindo Pharma receives USFDA Final Approval for Beclomethasone Dipropionate HFA Inhalation Aerosol

  NSE ↗
• Filing

  Aurobindo Pharma completes US FDA inspection at Apitoria Pharma Unit-II, a wholly owned subsidiary

  NSE ↗
• Filing

  US FDA final approval received for Beclomethasone Dipropionate HFA Inhalation Aerosol, 40 mcg and 80 mcg

  BSE ↗
• Filing

  US FDA inspection completed at Apitoria Pharma Unit-II subsidiary

  BSE ↗